febuxostat genericon 120 mg filmtabletten
genericon pharma gmbh - febuxostat hemihydrat -
febuxostat genericon 80 mg filmtabletten
genericon pharma gmbh - febuxostat hemihydrat -
hepacaf 5000 iu pulver und lösungsmittel zur herstellung einer infusionslösung
centrale afdeling voor fractionering (caf - humane anti-hepatitis-b-immunglobulin - pulver und lösungsmittel zur herstellung einer infusionslösung - 5000 iu - humane anti-hepatitis-b-immunglobulin 5000 iu - hepatitis b immunoglobulin
memfor 120 filmtablette
will pharma - ginkgo biloba l., blatt, trockenextrakt aceton 60 % 35-67_1 - filmtablette - ginkgo biloba l., blatt, trockenextrakt aceton 60 % 35-67_1 120 mg - ginkgo folium
memfor 240 filmtablette
will pharma - ginkgo biloba l., blatt, trockenextrakt aceton 60 % 35-67_1 - filmtablette - ginkgo biloba l., blatt, trockenextrakt aceton 60 % 35-67_1 240 mg - ginkgo folium
memfor 40 filmtablette
will pharma - ginkgo biloba l., blatt, trockenextrakt aceton 60 % 35-67_1 - filmtablette - ginkgo biloba l., blatt, trockenextrakt aceton 60 % 35-67_1 40 mg - ginkgo folium
memfor 80 filmtablette
will pharma - ginkgo biloba l., blatt, trockenextrakt aceton 60 % 35-67_1 - filmtablette - ginkgo biloba l., blatt, trockenextrakt aceton 60 % 35-67_1 80 mg - ginkgo folium
heplisav b
dynavax gmbh - hepatitis-b-oberflächenantigen - hepatitis b - impfstoffe - heplisav b is indicated for the active immunisation against hepatitis b virus infection (hbv) caused by all known subtypes of hepatitis b virus in adults 18 years of age and older. the use of heplisav b should be in accordance with official recommendations. it can be expected that hepatitis d will also be prevented by immunisation with heplisav b as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection.
prehevbri
vbi vaccines b.v. - hepatitis-b-oberflächenantigen - hepatitis b - impfstoffe - prehevbri is indicated for active immunisation against infection caused by all known subtypes of the hepatitis b virus in adults. it can be expected that hepatitis d will also be prevented by immunisation with prehevbri as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection. the use of prehevbri should be in accordance with official recommendations.
eslicarbazepin meditop 800 mg tabletten
meditop gyógyszeripari korlátolt felel?sség? társaság hr-beiname: meditop pharmaceutical ltd., meditop pharmaceutical limited liability company (8074334) - eslicarbazepinacetat - tablette - 800 mg - teil 1 - tablette; eslicarbazepinacetat (32337) 800 milligramm